
Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats
Author(s) -
Kosuke Tanaka,
Yuko Masaki,
Masanori Tanaka,
Masaru Miyazaki,
Munechika Enjoji,
Makoto Nakamuta,
Masaki Kato,
Masatoshi Nomura,
Toyoshi Inoguchi,
Kazuhiro Kotoh,
Ryoichi Takayanagi
Publication year - 2014
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v20.i10.2653
Subject(s) - exenatide , medicine , endocrinology , adipose tissue , steatosis , white adipose tissue , nonalcoholic fatty liver disease , lipid metabolism , fatty liver , brown adipose tissue , biology , type 2 diabetes , diabetes mellitus , disease
To investigate the metabolic changes in skeletal muscle and/or adipose tissue in glucagon-like peptide-1-induced improvement of nonalcoholic fatty liver disease (NAFLD).